DAVID J PINSKY, MD
Osteopathic Medicine in Ann Arbor, MI
License number
Michigan 4301081173
Category
Osteopathic Medicine
Type
Internal Medicine
License number
Michigan 4301081173
Category
Osteopathic Medicine
Type
Cardiovascular Disease
Address
Address
1500 Floor Cardiovascular Ctr, Ann Arbor, MI 48109
Phone
(888) 287-1082
(734) 936-2047
(734) 936-2047
Personal information
See more information about DAVID J PINSKY at radaris.comName
Address
Phone
3600 Daleview Dr, Ann Arbor, MI 48105
3610 Daleview Dr, Ann Arbor, MI 48105
3600 Daleview Dr, Ann Arbor, MI 48105
33 Barton North Dr, Ann Arbor, MI 48105
Professional information
Dr. David J Pinsky, Ann Arbor MI - MD (Doctor of Medicine)
Specialties:
Cardiology
Address:
1500 E Medical Center Dr SUITE 3, Ann Arbor 48109
(734) 647-7321 (Phone), (734) 936-7392 (Fax)
REGENTS OF THE UNIVERSITY OF MICHIGAN
1500 E Medical Center Dr SUITE 3914, Ann Arbor 48109
(734) 936-5548 (Phone), (734) 936-9621 (Fax)
(734) 647-7321 (Phone), (734) 936-7392 (Fax)
REGENTS OF THE UNIVERSITY OF MICHIGAN
1500 E Medical Center Dr SUITE 3914, Ann Arbor 48109
(734) 936-5548 (Phone), (734) 936-9621 (Fax)
Procedures:
Ablation for Treatment of Cardiac Arrythmias, Cardiac Catheterization (incl. Coronary Angiography), Cardiac Myocardial Perfusion Imaging, Cardioverter-Defibrillator or Pacemaker Insertion, Removal or Repair, Coronary Angioplasty, Atherectomy and Stent, Impella Device, Peripheral Artery Catheterization, Thoracentesis
Conditions:
Angina and Acute Coronary Syndrome, Aortic Valve Disease, Arrhythmias (incl. Atrial Fibrillation), Cardiomyopathy, Congenital Heart Disease, Congestive Heart Failure, Coronary Artery Disease (CAD), Heart Attack (Acute Myocardial Infarction), Hyperlipidemia, Hypertension, Hypertensive Heart and Chronic Kidney Disease, Hypotension, Mitral Valve Disease, Pulmonary Hypertension, Septal Defect, Tricuspid Valve Disease
Certifications:
Cardiovascular Disease, 2002, Internal Medicine, 1988
Awards:
Healthgrades Honor Roll
Languages:
English
Hospitals:
1500 E Medical Center Dr SUITE 3, Ann Arbor 48109
REGENTS OF THE UNIVERSITY OF MICHIGAN
1500 E Medical Center Dr SUITE 3914, Ann Arbor 48109
University of Michigan Health System
1500 East Medical Center Dr SPC 5474, Ann Arbor 48109
REGENTS OF THE UNIVERSITY OF MICHIGAN
1500 E Medical Center Dr SUITE 3914, Ann Arbor 48109
University of Michigan Health System
1500 East Medical Center Dr SPC 5474, Ann Arbor 48109
Education:
Medical School
Ohio State University / College of Medicine
Graduated: 1985
Mount Sinai Hospital
Ohio State University / College of Medicine
Graduated: 1985
Mount Sinai Hospital
Tissue Inhibitor Of Metalloproteinase (Timp) As A Marker And Predictor Of Cardiovascular Disease And Both Cardiac And Non-Cardiac Mortality
US Patent:
2006016, Jul 20, 2006
Filed:
Dec 1, 2005
Appl. No.:
11/292031
Inventors:
Erdal Cavusoglu - Douglaston NY, US
Jonathan Marmur - New York NY, US
David Pinsky - Ann Arbor MI, US
Cyril Ruwende - Ann Arbor MI, US
Jonathan Marmur - New York NY, US
David Pinsky - Ann Arbor MI, US
Cyril Ruwende - Ann Arbor MI, US
International Classification:
C12Q 1/68, G01N 33/53, G01N 33/00
US Classification:
435006000, 435007100, 436086000
Abstract:
The present invention is directed to a method for characterizing an individual's risk profile of developing vascular disease, for an adverse outcome in a patient, for mortality in an individual diagnosed with vascular disease by evaluating the level of tissue inhibitor of metalloproteinase-1 (TIMP-1) in a sample taken from the individual. The invention is also directed to a kit for characterizing the same.
David J Pinsky, Ann Arbor MI
Specialties:
Cardiologist
Address:
1500 E Medical Center Dr, Ann Arbor, MI 48109
Education:
Ohio State University, College of Medicine - Doctor of Medicine
Mount Sinai Hospital, The - Fellowship - Cardiology
Mount Sinai Hospital, The - Residency - Internal Medicine
Mount Sinai Hospital, The - Fellowship - Cardiology
Mount Sinai Hospital, The - Residency - Internal Medicine
Board certifications:
American Board of Internal Medicine Certification in Internal Medicine
Method For Enhancing Bone Formation
US Patent:
2006029, Dec 28, 2006
Filed:
Jul 29, 2005
Appl. No.:
11/193198
Inventors:
Regina Landesberg - Stamford CT, US
David Pinsky - Ann Arbor MI, US
Ronald Katz - Fayetteville NY, US
David Pinsky - Ann Arbor MI, US
Ronald Katz - Fayetteville NY, US
International Classification:
A61K 38/39, A61K 38/18
US Classification:
514012000
Abstract:
This invention provides a method for facilitating bone formation in a subject comprising delivering to a bone formation-requiring site a composition of matter comprising platelet-rich plasma, calcium, a PAR-activating agent and a bone forming material. This invention further provides a method for facilitating bone formation in a subject comprising (a) delivering to a bone formation-requiring site in the subject a composition of matter comprising platelet-rich plasma, calcium and a bone-forming material, and (b) contacting the composition so delivered with a PAR-activating agent other than thrombin. This invention further provides a method for facilitating clot formation in platelet-rich plasma with a PAR-activating agent other than thrombin. This invention further provides a method of producing a formable gel comprising the step of admixing platelet-rich plasma, calcium, a bone-forming material and a PAR-activating agent other than thrombin. Finally, this invention provides related compositions of matter and articles of manufacture.
Methods For Treating Ischemic Disorders Using Carbon Monoxide
US Patent:
8128963, Mar 6, 2012
Filed:
Oct 3, 2003
Appl. No.:
10/679135
Inventors:
David J. Pinsky - Ann Arbor MI, US
David M. Stern - Augusta GA, US
David M. Stern - Augusta GA, US
Assignee:
The Trustees of Columbia University in the City Of New York - New York NY
International Classification:
A61K 33/00, A61P 9/10
US Classification:
424699, 435 11
Abstract:
The present invention provides for a method for treating an ischemic disorder in a subject which comprises administering to the subject a pharmaceutically acceptable form of a selectin antagonist in a sufficient amount over a sufficient time period to prevent white blood cell accumulation so as to treat the ischemic disorder in the subject. The invention further provides a method for treating an ischemic disorder in a subject which comprises administering to the subject carbon monoxide gas in a sufficient amount over a sufficient period of time thereby treating the ischemic disorder in the subject. The invention further provides a method for treating an ischemic disorder in a subject which comprises administering to the subject a pharmaceutically acceptable form of inactivated Factor IX in a sufficient amount over a sufficient period of time to inhibit coagulation so as to treat the ischemic disorder in the subject.
Compositions And Methods For Ex Vivo Preservation Of Blood Vessels For Vascular Grafts Using Analogues Of Camp And Cgmp
US Patent:
2006013, Jun 22, 2006
Filed:
Jul 1, 2005
Appl. No.:
11/173537
Inventors:
Yoshifumi Naka - Cliffside Park NJ, US
David Pinsky - Ann Arbor MI, US
David Stern - Augusta GA, US
David Pinsky - Ann Arbor MI, US
David Stern - Augusta GA, US
International Classification:
C12N 5/08, A61K 35/14, A61K 31/7076, A61K 31/52
US Classification:
424093700, 435366000, 514046000, 514263240
Abstract:
The present invention relates to ex vivo methods for preserving/maintaining blood vessels that are to be used as vascular grafts. The present invention also relates to compositions comprising an analogue of cAMP and/or an analogue of cGMP for use in the methods of the invention, which compositions are free of: (i) an inhibitor of Type I phosphodiesterase, (ii) an inhibitor of Type II phosphodiesterase, (iii) an inhibitor of Type III phosphodiesterase, (iv) an inhibitor of Type IV phosphodiesterase, and (v) an inhibitor of TNF-α.
Nucleotide Phosphate Dissipation As A Treatment For Vascular Disorders
US Patent:
2009013, May 21, 2009
Filed:
Oct 30, 2008
Appl. No.:
12/261870
Inventors:
David J. Pinsky - Ann Arbor MI, US
International Classification:
A61K 39/395, A61K 38/43
US Classification:
4241301, 424 941
Abstract:
The present invention provides a method of treating or preventing immunoinflammatory, vascular, thrombotic or ischemic disorders in a subject, the method comprises administering to the subject an agent which dissipates nucleotide phosphates or generates a product which stimulates adenosine receptors. The present invention also provides a method of treating or preventing immunoinflammatory, thrombotic or ischemic disorders in a subject by inhibiting leukocyte infiltration into a site which comprises administering to the subject an effective amount a described agent. Agents described for use in the methods of the invention include CD73, a fragment a mutant, or a modified form thereof.